“Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review” (2024) Annals of Gastroenterology and Digestive Disorders, 7(1), pp. 32–6. doi:10.5281/zenodo.22179529.